ZDHHC16 acts as an upstream regulator of ZDHHC6, a palmitoyltransferase targeting ER proteins like calnexin and the transferrin receptor . Key findings:
Activity Modulation: ZDHHC16 palmitoylates ZDHHC6 at Cys-328, enhancing its catalytic activity. Non-palmitoylated ZDHHC6 lacks detectable function .
Dynamic Interconversion: ZDHHC6 exists in eight palmitoylated states (C000 to C111), rapidly interconverted via ZDHHC16 and depalmitoylase APT2 .
Species-Specific Activity: Bovine ZDHHC16 mirrors human ZDHHC16 in substrate specificity, as demonstrated in CRISPR KO models .
Studies highlight ZDHHC16’s role in pathological processes:
Cancer Therapy: Targeting ZDHHC16 in KRAS-mutant pancreatic cancer may disrupt oncogenic signaling (e.g., MYC stabilization via ZDHHC20) .
Stem Cell Engineering: Modulating ZDHHC16 could enhance osteogenic differentiation for tissue repair applications .
Biomarker Development: ZDHHC16 expression levels correlate with disease progression in pancreatic cancer .
ZDHHC16 is a member of the DHHC palmitoyltransferase family responsible for catalyzing S-palmitoylation, which is the only reversible post-translational lipid modification in cells. Specifically, ZDHHC16 functions as an upstream palmitoyltransferase in a palmitoylation cascade, where it controls ZDHHC6 activity through site-specific palmitoylation . This regulatory relationship represents the first identified palmitoylation cascade in cellular systems, conceptually similar to phosphorylation cascades like the MAPK pathway .
Under over-expression conditions, ZDHHC16 localizes to both the endoplasmic reticulum (ER) and Golgi apparatus . This localization is consistent with its function in regulating ZDHHC6, which modifies key proteins of the endoplasmic reticulum. Unlike many other DHHC family members, ZDHHC16 itself is not palmitoylated in HeLa cells, as demonstrated by both 3H-palmitate incorporation assays and Acyl-RAC methodology .
ZDHHC16 and ZDHHC6 form a regulatory cascade where:
ZDHHC16 acts as the upstream enzyme that palmitoylates ZDHHC6 on its cysteine residues
The two enzymes physically interact, as demonstrated by co-immunoprecipitation experiments with myc-tagged ZDHHC6 and FLAG-tagged ZDHHC16
They exhibit genetic interaction, where ZDHHC6 silencing or knockout leads to increased ZDHHC16 mRNA expression
ZDHHC16 regulates ZDHHC6 activity through modulating its palmitoylation state, which affects ZDHHC6's ability to palmitoylate its own substrates, including calnexin and transferrin receptor
Recombinant full-length bovine ZDHHC16 protein can be produced using bacterial expression systems. According to the available product information, bovine ZDHHC16 (Q58CU4) spanning amino acids 1-377 can be expressed in E. coli with an N-terminal His tag for purification purposes . This approach provides a standardized source of the enzyme for in vitro studies of its activity, interaction partners, and regulatory mechanisms.
Several complementary approaches have proven effective for investigating the ZDHHC16-ZDHHC6 relationship:
Co-immunoprecipitation with tagged proteins to demonstrate physical interaction
Acyl-RAC (resin-assisted capture) to isolate and identify palmitoylated proteins
3H-palmitate pulse-chase experiments to study palmitate turnover dynamics
CRISPR-Cas9 knockout of ZDHHC genes to verify specificity of enzymatic relationships
siRNA screens to identify enzymes involved in specific palmitoylation events
Site-specific mutagenesis of cysteine residues to determine palmitoylation sites
Multiple complementary techniques have been successfully applied:
Radioactive labeling: 3H-palmitate incorporation provides direct evidence of palmitoylation and allows quantification of palmitate turnover rates
Acyl-RAC method: Allows isolation of palmitoylated proteins without radioactivity
PEGylation assays: Can be used to confirm changes in palmitoylation states
Western blot analysis: For determining protein expression levels and stability
Data-driven mathematical modeling: Enables prediction of species distribution and dynamics based on experimental parameters
The palmitoylation state of ZDHHC6 dramatically affects both its stability and enzymatic activity. Research reveals eight differentially palmitoylated ZDHHC6 species with distinct characteristics:
Palmitoylation on Cys-328 strongly accelerates protein turnover, regardless of other sites (t1/2=5 hr for C100 and t1/2=0.3 hr for C111)
Palmitoylation on Cys-329 has a stabilizing effect on the protein
The non-palmitoylated form (C000) has a half-life of approximately 40 hours
When ZDHHC16 activity is high, the C011 species (palmitoylated on Cys-329 and Cys-330 but not Cys-328) becomes the hub of the system
The presence of all three palmitoylation sites renders ZDHHC6 protein content robust to changes in ZDHHC16 activity
A comprehensive mathematical model has been developed that captures the complexity of the ZDHHC6 palmitoylation system. This model:
Accurately predicts experimental results not used for model calibration
Estimates half-lives for different ZDHHC6 species
Models the effects of ZDHHC16 overexpression and APT2 (depalmitoylation enzyme) silencing
Predicts changes in species distribution under various experimental conditions
Enables stochastic simulations that reveal dynamic properties of the network
| ZDHHC6 Species | Predicted Half-life | Effect of ZDHHC16 Overexpression |
|---|---|---|
| C000 (non-palmitoylated) | ~40 hours | Decreases abundance |
| C100 (Cys-328 only) | ~5 hours | Variable |
| C111 (all sites) | ~0.3 hours | Increases abundance |
| C011 (Cys-329 & Cys-330) | Not specified | Becomes dominant species (60%) |
Experimental evidence indicates that ZDHHC16-mediated palmitoylation of ZDHHC6 affects its ability to modify reported substrates in a cellular context:
Working with recombinant palmitoyltransferases presents several technical challenges:
Maintaining enzyme activity after purification, as these are membrane proteins that require proper folding
Establishing appropriate in vitro assay conditions that reflect physiological activity
Distinguishing between auto-palmitoylation and substrate palmitoylation activities
Ensuring specific detection of palmitoylation events when multiple modification sites are present
Accounting for potential interactions with endogenous enzymes when overexpressing recombinant proteins in cellular systems
The literature demonstrates successful approaches for manipulating ZDHHC16 expression:
CRISPR-Cas9 technology: Successfully used to generate ZDHHC16 knockout cell lines, particularly in the near-haploid HAP1 cell line
siRNA-mediated silencing: Effective for transient knockdown experiments in various cell types
Over-expression experiments: Complementary approach to loss-of-function studies, allowing observation of gain-of-function effects
When validating knockdown or knockout, it is essential to confirm the specificity of the effect by:
Measuring target protein levels via Western blot
Assessing effects on known substrates (e.g., calnexin and transferrin receptor palmitoylation for ZDHHC6)
Performing rescue experiments with WT or mutant constructs
The ZDHHC16-ZDHHC6 cascade represents a regulatory mechanism for controlling palmitoylation of critical ER proteins, including:
This cascade provides a sophisticated mechanism for cells to tune ZDHHC6 activity through rapid interconversion between differently palmitoylated species mediated by ZDHHC16 and the depalmitoylating enzyme APT2 . The robustness of this system suggests it may be crucial for maintaining ER homeostasis under various cellular conditions.
The ZDHHC16-ZDHHC6 relationship represents the first identified palmitoylation cascade, conceptually similar to phosphorylation cascades like the MAPK pathway . While other cascades have not been definitively identified, the discovery of this system suggests that hierarchical regulation may be a broader feature of the palmitoylation machinery. Future research should investigate potential cascades involving other members of the 23 DHHC family enzymes in humans.
Several research avenues hold significant promise:
Structural studies: Determining the three-dimensional structure of ZDHHC16 to understand its mechanism of action
Substrate specificity: Comprehensive profiling of ZDHHC16 substrates beyond ZDHHC6
Physiological regulation: Understanding how ZDHHC16 activity is controlled under various cellular conditions
Disease relevance: Investigating potential roles in pathological conditions
Systems biology approaches: Expanding mathematical models to include additional components of palmitoylation networks